Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06272305
Other study ID # 49RC21_0301
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date March 1, 2024
Est. completion date June 1, 2024

Study information

Verified date February 2024
Source University Hospital, Angers
Contact Gautier HAUPERT, Dr
Phone 02 41 35 38 38
Email gautier.haupert@chu-angers.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Restenosis due to myo-intimal hyperplasia remains a concern after carotid endarterectomy. It occurs in around 6% of cases. Several risk factors for restenosis have already been identified, such as smoking, hypertension, female gender, diabetes, dyslipidemia and small carotid diameter. The main objective of this prospective multicenter study was to determine whether the technical characteristics of the eversion technique have an influence on the rate of restenosis at 1 year. Between September 2021 and November 2022, we followed all patients undergoing carotid endarterectomy by eversion in 8 French hospitals. Demographic data, operative indications and technical characteristics of the endarterectomies performed were collected. These were defined by the circumferential nature of the carotid bulb according to 3 types (TREC A, B or C), and the length and depth of the endarterectomy according to anatomopathological reports. Post-operative complications were collected as much as doppler ultrasonography at three months and 1 year to quantify restenosis.


Description:

Before the surgery, the following data is collected : - General data: Sex, age, weight, height - History and cardiovascular risk factors: diabetes, high blood pressure, dyslipidemia, smoking, chronic renal failure, etc. - Current treatments taken by the patient - The degree of initial stenosis of the carotid artery of interest on duplex ultrasound as well as on CT angiography - The context of endarterectomy if it occurs following a stroke or preventively. Data to be recovered post-operatively from carotid surgery : - The operative report specifying the circumferential nature of the carotid endarterectomy on the common carotid-external carotid axis. 3 possible categories: no endarterectomy, non-circumferential partial endarterectomy, circumferential endarterectomy. - Post-operative doppler (< 1 month) assessing the presence of residual stenosis. - The patient's operative consequences with the occurrence of intercurrent cardiological events (cardiological, biological or electrocardiographic), neurological (central or peripheral), post-operative complications such as cervical hematoma. Visit between month 1 and month 3 : - The anatomopathological report specifying: Length of the endarterectomy part in millimeters and the depth of the endarterectomy according to the location of the separation plane at the level of the artery wall (deep or superficial intimal plane). - Doppler assessing the presence of carotid restenosis - The occurrence of central neurological events that may be related to the endarterectomized carotid artery Visit at one year : - Doppler assessing the presence of carotid restenosis - The occurrence of central neurological events that may be related to the endarterectomized carotid artery


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 500
Est. completion date June 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Any patient who is having carotid endarterectomy by eversion according to HAS + ESVS recommendations : - Stenosis > 70% on dopplerin the absence of neurological symptoms attributable to the carotid territory affected by the stenotic artery. - Stenosis > 50% with neurological symptoms attributable to the carotid territory affected by the stenotic artery. Exclusion Criteria: - Any carotid revascularization technique other than eversion (carotid endarterectomy with patch, carotid resection-anastomosis or bypass). - Cardiac surgery combined with carotid surgery - Minor patients - Endovascular carotid surgery - Opposition to use patient's data

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
This research does not require any specific investigation and does not imply any modification of treatment.
Collection of data from the medical record for patients with a non specific carotid endarterectomy

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Angers

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of restenosis The main objective is to evaluate the rate of restenosis at doppler(defined as restenosis =50%(NASCET/ECST)) occurring at one year, according to the technical characteristics of the eversion. They are defined according to three distinct criteria: the circumferential nature of the endarterectomy at the level of the carotid bifurcation, the length of the endarterectomy and its depth in the plane of the intima. one year
Secondary Morbidity and mortality rate Cumulative morbidity and mortality rate at 30 days defined by:
All-cause mortality within 30 days post-op
Major neurological event defined as the occurrence of a stroke (focal signs lasting more than 24 hours, confirmed by brain imaging)
30 days
Secondary Major cardiological event Major cardiological event defined by troponin elevation with chest pain (or equivalent symptom) and/or ECG changes in favor of myocardial ischemia one year
Secondary Minor neurological events Minor neurological events: peripheral neurological and/or cranial nerve damage (tongue deviation, dysphonia, swallowing disorder). one year
See also
  Status Clinical Trial Phase
Recruiting NCT00774917 - Numen Stent Assessment Using OCT Technique in a Single Center Study Phase 2/Phase 3
Recruiting NCT00496639 - Stent vs. Angioplasty for Treatment of Thrombosed AV Grafts: Long-Term Outcomes N/A
Recruiting NCT02592473 - Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia N/A
Completed NCT02063919 - Association Between Confocal Laser Endomicroscopic (CLE) Features and Colorectal Mucosal Microbiome N/A
Completed NCT00041925 - Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures Phase 2/Phase 3
Terminated NCT00086164 - Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis Phase 1/Phase 2
Terminated NCT00819260 - Harmonic Scalpel Vs. Electrocautery in Breast Reduction Surgery N/A
Terminated NCT01033357 - Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access N/A
Withdrawn NCT02871050 - Castleman Disease Collaborative Network Biobank
Active, not recruiting NCT02581137 - Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion Phase 2
Completed NCT03268993 - Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer N/A
Active, not recruiting NCT01816438 - A French Non Interventional Multicentric Cohort Study in Patients With Colorectal Dysplasia
Completed NCT01118260 - Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection Phase 4
Completed NCT03718234 - Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia Phase 1
Withdrawn NCT01203371 - Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS Phase 3
Completed NCT02853968 - Unlock the Cell: Castleman's Disease Flow Cytometry Study
Recruiting NCT00524823 - Early Detection of Prostate Cancer by FACS Phase 4
Completed NCT03182959 - Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer Early Phase 1
Recruiting NCT02505256 - Study Into Treatment of Hyperplasia of Mammary Glands N/A